House Democrats' plans to lower prescription drug prices by allowing medicare to put a cap on prices.
HealthPrize technology CEO Tom Kottler discusses a Federal Judge's decision to block the Trump administration from forcing drug companies from disclosing pricing on television.
Merck is cutting prices on 7 drugs.
Spinraza, a newly approved drug for spinal muscular atrophy has faced slow ramp-ups at hospitals and resistance by health insurers spooked by the $750,000 list price.
Prices of prescription drugs have skyrocketed in recent years.